| Issue |
Section |
Title |
File |
| Vol 16, No 4 (2017) |
Статьи |
Blinatumomab therapy for relapsed and refractory acute lymphoblastic leukemia |
(Rus)
|
| Vol 17, No 1 (2018) |
Статьи |
Intrachromosomal amplification of chromosome 21 (iAMP21) is the marker of unfavorable prognosis in childhood B-cell precursor acute lymphoblastic leukemia |
(Rus)
|
| Vol 17, No 1 (2018) |
Статьи |
Endoscopy for children with thrombocytopenia: Single center experience |
(Rus)
|
| Vol 17, No 1 (2018) |
Статьи |
Hodgkin's lymphoma relapses and refractory forms therapy variants in children, adolescents and young adults |
(Rus)
|
| Vol 16, No 3 (2017) |
Статьи |
The results of pilot trial ALL-REZ-MВ-2014 for children with relapsed acute lymphoblastic leukemia |
(Rus)
|
| Vol 14, No 1 (2015) |
ОСТРЫЙ ЛИМФОБЛАСТНЫЙ ЛЕЙКОЗ |
Comparative analysis of dexamethasone and methylprednisolone efficacy in induction therapy of childhood acute lymphoblastic leukemia: Results of ALL-MB 2002 multicenter study |
(Rus)
|
| Vol 14, No 1 (2015) |
ОСТРЫЙ ЛИМФОБЛАСТНЫЙ ЛЕЙКОЗ |
Therapy of childhood T-cell acute lymphoblastic leukemia: Experience gained by the Russian-Byelorussian cooperative group |
(Rus)
|
| Vol 14, No 1 (2015) |
IMAGES |
Multifocal bone involvement in a patient with acute lymphoblastic leukemia |
(Rus)
|
| Vol 14, No 2 (2015) |
ЛИМФОМЫ |
Nodular lymphocyte-predominant Hodgkin’s lymphoma |
(Rus)
|
| Vol 14, No 2 (2015) |
ЛИМФОМЫ |
ALK-positive anaplastic large cell lymphoma: Diagnosis, clinical manifestation, therapy |
(Rus)
|
| Vol 14, No 2 (2015) |
ЛИМФОМЫ |
Brentuximab vedotin in therapy of a patient with refractory Hodgkin’s lymphoma and Proteus syndrome |
(Rus)
|
| Vol 14, No 2 (2015) |
ЛИМФОМЫ |
Cerebral venous sinus thrombosis and bleeding in the brain in a patient with lymphoblastic lymphoma |
(Rus)
|
| Vol 14, No 2 (2015) |
ЛИМФОМЫ |
A clinical case of metachronous presentation of B-cell unclassified lymphoma, intermediate between Hodgkin's lymphoma and diffuse B-large cell lymphoma (“gray zone” lymphoma) |
(Rus)
|
| Vol 14, No 4 (2015) |
ONCOLOGY |
Ommaya reservoir for intraventricular chemotherapy of children with neuro-oncological and oncohematological diseases: Design history, implantation technology, and experience gained at the Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev |
(Rus)
|
| Vol 15, No 1 (2016) |
IMAGES |
Clinical case: Castleman’s disease |
(Rus)
|
| Vol 18, No 1 (2019) |
PROMISING STUDIES |
First results of pilot protocol ALl-REZ-2016 for children with high risk groups of relapsed acute lymphoblastic leukemia |
(Rus)
|
| Vol 18, No 1 (2019) |
ORIGINAL ARTICLES |
Efficacy and toxicity of the treatment of children and adolescents with Hodgkin Lymphoma by GPOH-HD-2002 protocol |
(Rus)
|
| Vol 18, No 1 (2019) |
CLINICAL OBSERVATIONS |
Panniculitis-like T-cell lymphoma in children |
(Rus)
|
| Vol 18, No 1 (2019) |
CLINICAL OBSERVATIONS |
B-cell lymphoma is unclassifiable, with signs intermediate between diffuse large-cell B-cell lymphoma and Hodgkin lymphoma |
(Rus)
|
| Vol 18, No 2 (2019) |
LITERATURE REVIEW |
Steroid cataract in patients with hemoblastosis |
(Rus)
|
| Vol 19, No 1 (2020) |
ORIGINAL ARTICLES |
The experience of using the Brentuximab vedotin in the treatment of children and young adults with primary refractory course and relapses of Hodgkin's lymphoma |
(Rus)
|
| Vol 19, No 3 (2020) |
CLINICAL OBSERVATIONS |
Features of relapses and refractory forms of T-lymphoblastic lymphoma in children |
(Rus)
|
| Vol 19, No 4 (2020) |
LITERATURE REVIEW |
Prognostic markers of lymphoblastic lymphoma |
(Rus)
|
| Vol 20, No 1 (2021) |
PROMISING STUDIES |
Acute lymphoblastic leukemia in children with Down syndrome: “Moscow–Berlin” experience |
(Rus)
|
| Vol 20, No 1 (2021) |
ORIGINAL ARTICLES |
Prognostic significance of various 11q23/KMT2A rearrangements in infants with acute lymphoblastic leuekemia |
(Rus)
|
| Vol 20, No 1 (2021) |
CLINICAL OBSERVATIONS |
A rare case of nodular lymphocyte predominant Hodgkin lymphoma, which developed 5 years after successful treatment of diffuse large B-cell lymphoma |
(Rus)
|
| Vol 20, No 2 (2021) |
ORIGINAL ARTICLES |
Nodular lymphocyte-predominant Hodgkin Lymphoma in children. Retrospective clinical and morphological analysis of the patients. One Center experience |
(Rus)
|
| Vol 20, No 3 (2021) |
ORIGINAL ARTICLES |
Incidence of venous thromboembolism in children with primary lymphomas |
(Rus)
|
| Vol 21, No 1 (2022) |
LITERATURE REVIEW |
Predictive value of metabolic parameters of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography for survival rates of children with lymphoma (a metaanalysis and literature review) |
(Rus)
|
| Vol 21, No 1 (2022) |
CLINICAL OBSERVATIONS |
Treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin’s lymphoma (gray zone lymphoma) in children and young adults: a case series |
(Rus)
|
| Vol 21, No 3 (2022) |
ORIGINAL ARTICLES |
Clinical and laboratory characteristics of a group of patients with ataxia-telangiectasia syndrome |
(Rus)
|
| Vol 21, No 4 (2022) |
CLINICAL OBSERVATIONS |
Malignant gastrointestinal neuroectodermal tumor |
(Rus)
|
| Vol 21, No 3 (2022) |
ORIGINAL ARTICLES |
High-risk acute lymphoblastic leukemia in the ALL-MB 2002 study |
(Rus)
|
| Vol 21, No 3 (2022) |
CLINICAL OBSERVATIONS |
Acute lymphoblastic leukemia with the t(17;19) translocation: hope has appeared! Multimodal immunotherapy in a 3-year-old child with refractory disease: a case report |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
Treatment of lymphoid malignancies in patients with primary immunodeficiencies associated with DNA repair defects |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The evaluation of minimal disseminated disease in the bone marrow of children with Burkitt lymphoma using next generation sequencing |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The use of inotuzumab ozogamicin in children with relapsed/refractory B-lineage acute lymphoblastic leukemia |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The role of blinatumomab in the treatment of B-cell relapses of acute lymphoblastic leukemia in children: own experience |
(Rus)
|
| Vol 22, No 1 (2023) |
CLINICAL OBSERVATIONS |
Rosai–Dorfman disease (sinus histiocytosis with massive lymphadenopathy): personal observations and literature review |
(Rus)
|
| Vol 22, No 1 (2023) |
CLINICAL OBSERVATIONS |
Heart failure as a manifestation of acute lymphoblastic leukemia |
(Rus)
|
| Vol 22, No 1 (2023) |
CLINICAL OBSERVATIONS |
Progressive transformation of germinal centers or nodular lymphocyte-predominant Hodgkin lymphoma? Issues of differential diagnosis: a clinical case |
(Rus)
|
| Vol 22, No 3 (2023) |
ORIGINAL ARTICLES |
Quantitative bone marrow magnetic resonance imaging in children with lymphoblastic leukaemia |
(Rus)
|
| Vol 22, No 2 (2023) |
CLINICAL OBSERVATIONS |
Mycosis fungoides in an 11 year-old child: a case report |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
Visual and quantitative assessment of interim 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in children with Hodgkin lymphoma |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
The prognostic value of TP53 mutational status in children with Burkitt lymphoma treated according to the B-NHL-2010M protocol |
(Rus)
|
| Vol 22, No 4 (2023) |
ORIGINAL ARTICLES |
Flow cytometric and cytomorphological definition of remission achievement in children with B-lineage acute lymphoblastic leukemia |
(Rus)
|
| Vol 23, No 1 (2024) |
LITERATURE REVIEW |
Current views on the etiology and pathogenesis of ALK-positive anaplastic large cell lymphoma |
(Rus)
|
| Vol 23, No 1 (2024) |
LITERATURE REVIEW |
Molecular pathogenesis of T-lymphoblastic lymphoma |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
Bispecific monoclonal antibody blinatumomab in the first-line therapy of B-lineage acute lymphoblastic leukemia in children and adolescents: interim results of the Russian Ministry of Health approbation protocol |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
The impact of immunoarchitectural patterns on clinical presentation and response to therapy in children with nodular lymphocyte predominant Hodgkin lymphoma |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
The use of blinatumomab in children with de novo Ph-negative B-lineage acute lymphoblastic leukemia and slow clearance of minimal residual disease |
(Rus)
|
| Vol 23, No 1 (2024) |
CLINICAL OBSERVATIONS |
Immune checkpoint inhibitor therapy in children and adolescents with refractory/relapsed Hodgkin lymphoma: a case series |
(Rus)
|
| Vol 23, No 3 (2024) |
ORIGINAL ARTICLES |
The prognostic value of the morhological types of ALK-positive anaplastic large cell lymphoma in children |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Leukemia with L3 morphology: cytogenetic characterization and diagnostic challenges |
(Rus)
|
| Vol 24, No 1 (2025) |
LITERATURE REVIEW |
Modern concepts in the treatment of classical Hodgkin lymphoma in children and adolescents |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Pegylated asparaginase during induction therapy in children with intermediate-risk acute lymphoblastic leukemia: results of a randomized study |
(Rus)
|
